ASCO Daily News

101 Jaksot

1. Spotlight on Immunotherapy at ASCO23

   Julkaistiin: 26.6.2023
2. Highlights in Hematologic Malignancies at ASCO23 

   Julkaistiin: 23.6.2023
3. ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23

   Julkaistiin: 22.6.2023
4. SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23

   Julkaistiin: 21.6.2023
5. Addressing the Impact of Prior Authorization on Access to Cancer Treatment

   Julkaistiin: 8.6.2023
6. ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy

   Julkaistiin: 25.5.2023
7. ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies

   Julkaistiin: 25.5.2023
8. ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer

   Julkaistiin: 25.5.2023
9. ASCO23: CodeBreak-101, NAPOLI-3, and Other Advances in GI Cancers

   Julkaistiin: 25.5.2023
10. ASCO23: Novel Therapies in Lung Cancer 

    Julkaistiin: 25.5.2023
11. ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer

    Julkaistiin: 25.5.2023
12. ASCO23: Key Abstracts from Precision Oncology to Cancer Disparities

    Julkaistiin: 25.5.2023
13. S2302 Pragmatica-Lung and the Promise of Streamlined Clinical Trials

    Julkaistiin: 13.4.2023
14. Advances in Neoadjuvant IO in MSI-H/dMMR Colorectal Cancer

    Julkaistiin: 16.3.2023
15. Key Abstracts in Prostate, Bladder, and Kidney Cancers at GU23

    Julkaistiin: 2.3.2023
16. ARASENS, TRITON3, and Other Key Advances at GU23

    Julkaistiin: 13.2.2023
17. SWOG 1815, PARADIGM, and Other Advances at GI23

    Julkaistiin: 2.2.2023
18. Fertility Concerns, Family Planning, and Career Decisions Among Female Oncologists

    Julkaistiin: 5.1.2023
19. What Challenges Will Oncologists Face in 2023?

    Julkaistiin: 8.12.2022
20. Developing the Next Generation of Prostate Cancer Researchers

    Julkaistiin: 15.11.2022